Published in J Immunol on January 17, 2014
Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology. MBio (2015) 0.98
Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in Rats. Invest Ophthalmol Vis Sci (2015) 0.81
Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol (2014) 0.81
A Central Role for Sympathetic Nerves in Herpes Stromal Keratitis in Mice. Invest Ophthalmol Vis Sci (2016) 0.80
Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice. Invest Ophthalmol Vis Sci (2015) 0.80
Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation. J Neurovirol (2015) 0.80
Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice. Curr Eye Res (2015) 0.79
Pattern recognition receptors in microbial keratitis. Eye (Lond) (2015) 0.76
CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection. J Leukoc Biol (2016) 0.75
CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis. Virology (2017) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A (2002) 2.94
Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol (1989) 2.24
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell (2002) 1.73
Herpes keratitis. Prog Retin Eye Res (2012) 1.55
Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol (2011) 1.53
Ocular effects of topical and systemic steroids. Dermatol Clin (1992) 1.48
CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis. J Leukoc Biol (2006) 1.44
Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci (2002) 1.34
Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis (2009) 1.25
Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis (2008) 1.24
Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology (2006) 1.24
Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. J Immunol (1993) 1.17
Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J Virol (2000) 1.17
Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol Vis Sci (2008) 1.15
Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J Immunol (2011) 1.14
CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol (2004) 1.11
CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol (2004) 1.09
Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res (1998) 1.06
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J Virol (2002) 1.04
IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J Immunol (2012) 1.04
Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci (2001) 0.99
Ocular herpes simplex infection: pathogenesis and current therapy. Mayo Clin Proc (1988) 0.97
CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis. J Immunol (2012) 0.96
Recurrent herpetic stromal keratitis in mice: a model for studying human HSK. Clin Dev Immunol (2012) 0.92
Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers). Drugs (2011) 0.91
Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest Ophthalmol Vis Sci (2007) 0.89
Induction of IL-6 in transcriptional networks in corneal epithelial cells after herpes simplex virus type 1 infection. Invest Ophthalmol Vis Sci (2009) 0.88
Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1. J Immunol (2011) 0.86
CCL3 protects mice from corneal pathology during recurrent HSV-1 infection. Front Biosci (2008) 0.86
Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch Virol (1999) 0.85
Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice. J Virol (2013) 0.84
Resident Corneal Cells Communicate with Neutrophils Leading to the Production of IP-10 during the Primary Inflammatory Response to HSV-1 Infection. Int J Inflam (2012) 0.81
Photographic monitoring of herpes simplex virus keratitis during anti-inflammatory treatment. Arch Ophthalmol (2011) 0.79
Topical corticosteroids and cataract. Indian J Ophthalmol (1988) 0.79
Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins. Immunol Rev (2003) 1.10
CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest Ophthalmol Vis Sci (2006) 1.05
Peripheral deletion of antigen-specific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells. J Immunol (2005) 1.05
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J Virol (2002) 1.04
Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice. J Gen Virol (2002) 1.02
Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis. Microb Pathog (2004) 0.94
Interferon gamma is not required for recurrent herpetic stromal keratitis. Virology (2008) 0.87
Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1. J Immunol (2011) 0.86
Recurrent herpetic stromal keratitis in mice, a model for studying human HSK. J Vis Exp (2012) 0.86
The effects of aminoguanidine on primary and recurrent ocular herpes simplex virus infection. Nitric Oxide (2005) 0.85
Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways. J Neuroimmunol (2008) 0.83
Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice. Invest Ophthalmol Vis Sci (2015) 0.80
FasL, leukocytes and vascular modeling. Nat Med (2004) 0.76